American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • 2017
  • »
  • January

CVS head addresses investors at health care conference

American Pharmacy News Reports | Jan 11, 2017
Larry Merlo spoke to investors this week.
Larry Merlo spoke to investors this week. | Contributed photo
CVS Health Corp. President and CEO Larry Merlo spoke to investors this week at the 35th Annual J.P. Morgan Healthcare Conference.
An audio webcast of the event is available on the CVS website, under the Investor Relations section. 
The conference will continue through Friday in San Francisco.
More News

B. Douglas Hoey CEO

State Issues Tennessee enacts law banning pharmacy benefit managers from owning pharmacies May 22, 2026

Anne McDonald Pritchett, PhD, founder of Pritchett Policy Associates

Industry Pritchett Policy Associates founder Pritchett on biosimilar access: 'PBMs are the problem not patents' May 22, 2026

Ryan Long, Director of Congressional Relations & Senior Research Fellow at Paragon Health Institute

Federal Issues Paragon Health Institute senior fellow calls for 340B reform: Primary recipients of 340B are ‘wealthier larger hospital systems’ May 22, 2026

West Cuthbert, Senior Fellow, American Resolve Action

Federal Issues American Resolve Action Senior Fellow on 340B reform: Oversight 'could prevent billions of dollars in annual waste, fraud, and abuse' May 22, 2026

B. Douglas Hoey CEO

State Issues NCPA supports pharmacy bills being marked up in House committees May 21, 2026

B. Douglas Hoey CEO

State Issues NCPA responds to HHS OIG report on vertical integration in Medicare Part D May 21, 2026

Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Paul Gigot, Editor-in-chief, Wall Street Journal

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling

Katy Talento, Former Health Policy Advisor at the White House

Former White House health policy advisor Talento on Medicare PBMs: 'Why is Medicare using PBMs at all?'

Joe Grogan, Senior Fellow at USC Schaeffer

USC Schaeffer Center Senior Fellow on 340B: 'It's malpractice for Congress having a created a program that is totally out of control to not step in a fix this'

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up